1. P264 Impact of the HLA-DQ1*05 alelle on the initial response to infliximab in patients with Inflammatory Bowel Disease. (27th May 2021) Authors: Suris Marin, G; Santacana, E; Padullés, N; Padró, A; Serra, K; Ruiz, A; Blat, R; Arajol, C; Sanchez, E; Berrozpe, A; Rodríguez-Alonso, L; Rodríguez-Moranta, F; Guardiola, J Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P635 Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to infliximab in patients with inflammatory bowel disease. (25th January 2019) Authors: Guardiola, J; Rodriguez Alonso, L; Santacana, E; Padró, A; Serra, K; Padullés, N; Ruiz-Cerulla, A; Gilabert, P; Arajol, C; Ibañez-Sanz, G; Camps, B; Orobitg, J; Serracarbasa, A; de la Peña, L; Berrozpe, A; Rodriguez Moranta, F Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗